Translational Drug Abuse Prevention (TDAP)

Based on Research Conducted at OSLC

The TDAP Center focuses on broadening our understanding of underlying mechanisms that contribute to healthy development and testing practical interventions and implementation strategies to improve outcomes for children and families involved in U.S. child welfare systems.

Project Overview

OSLC, in collaboration with the University of Oregon and the University of Southern California, received a $9 Million grant from National Institute on Drug Abuse to launch the Translational Drug Abuse Prevention (TDAP) Center. The grant is one of the largest ever received by OSLC.  The project, led by scientists Dr. Patricia Chamberlain and Dr. Phil Fisher, includes a group of multidisciplinary scientists from OSLC and its partner organizations, who are collaborating to create a national resource for cutting-edge, innovative research with studies spanning from basic science to implementation research in U.S. child welfare systems. Children and adolescents involved in child welfare are among the most disadvantaged individuals in American society and are at greatly elevated risk for drug use and related problems including delinquency, teen pregnancy, poor physical and mental health, homelessness, incarceration, and HIV-risk behaviors. Moreover, long-term follow up studies show that even with existing community-based services, for many children involved in child welfare these problems prove intractable into adulthood. The TDAP Center focuses on broadening our understanding of underlying mechanisms that contribute to healthy development and testing practical interventions and implementation strategies to improve outcomes for children and families involved in U.S. child welfare systems.

Year Project Began: 2013
Funder: National Institute on Drug Abuse

Principal Investigator

Patricia Chamberlain, Ph.D.

Science Director
Oregon Social Learning Center

Active Research Projects

Primary Research and Clinical Interests

Dr. Chamberlain’s interest in developing interventions for children and families emerged from her early work as a special education teacher. She has conducted several studies on treatment for children, youth, and families in the child welfare, juvenile justice, and mental health systems. She founded the Treatment Foster Care Oregon (formerly Multidimensional Treatment Foster Care/MTFC; www.tfcoregon.com) and KEEP (www.keepfostering.org) intervention models. TFCO is an alternative to group, residential, and institutional placement for youngsters with high behavioral and emotional needs. KEEP provides enhanced support and training to state foster and relative parents to prevent placement disruptions, improve reunification rates, and to reduce parent stress and child behavioral and emotional problems. TFCO and KEEP are being widely implemented throughout the United States and in Europe (see www.tfcoregon.com and keepfostering.org). Dr. Chamberlain has been the Principal Investigator on 9 randomized trials examining the efficacy of parent mediated intervention approaches. She has been the P.I. on two P50 Centers of Excellence. She currently is focused on implementation research with an emphasis on what it takes to integrate and scale-up evidence-based practices into real-world agencies and systems. Since 2012, she has led an effort to implement KEEP and Parent Management Training in the New York City child welfare system involving over 300 case workers and supervisors serving over 2,000 children and families at 11 sites (CSNYC). Currently, she is leading an effort to implement KEEP statewide in Tennessee as part of In Home Tennessee, their Title IVE waiver program. Other recent work has also focused on the development of intervention models for adolescent girls in the juvenile justice and child welfare systems. In addition to working on research aimed at improving outcomes for youth and foster and biological families, she is interested in how to support child public service systems to improve the efficiency of their routine practices. Dr. Chamberlain is a senior fellow at the Society for Prevention Research (SPR), and was inducted into the first cohort of SPR Fellows in 2013. In 2017 she received the Prevention Science award given for leadership and promoting positive public health impacts.